LAUSR

surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism. J. Clin. Endocrinol. Metab. 2010; 95: 2736–45. 13 Kawate H, Kohno M, Matsuda Y et al. Long-term study of subclinical Cushing’s syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors. Endocr. J. 2014; 61: 1205–12. 14 Fassnacht M, Arlt W, Bancos I et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 2016; 175: G1–34. 15 Terzolo M, Stigliano A, Chiodini I et al. AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 2011; 164: 851–70. 16 NIH Consensus Development Program. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens. State Sci. Statements 2002; 19: 1–25. 17 Nieman LK, Biller BM, Findling JW et al. The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline. J. Clin. Endocr. Metab. 2008; 93: 1526–40. 18 Zeiger MA, Thompson GB, Duh QY et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr. Pract. 2009; 15(Suppl 1): 1–20. 19 Tabarin A, Bardet S, Bertherat J et al. Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus. Ann. Endocrinol. 2008; 69: 487–500. 20 Nawata HDH, Suda T, Takayanagi R. Adrenal preclinical Cushing’s syndrome. Annual report of the Ministry of Health and Welfare “Disorder of Adrenal Hormones”. Endocr. J. 1996; 195: 223–6. 21 Morelli V, Reimondo G, Giordano R et al. Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. J. Clin. Endocrinol. Metab. 2014; 99(3): 827–34. 22 Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur. J. Endocrinol. 2002; 146: 61–6. 23 Giorgi RB, Correa MV, Costa-Barbosa FA, Kater CE. Cyclic subclinical hypercortisolism: a previously unidentified hypersecretory form of adrenal incidentalomas. J. Endocr. Soc. 2019; 3: 678–86.